![Garry Michael Kann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Garry Michael Kann
Corporate Officer/Principal presso
ENDONOVO THERAPEUTICS, INC.
Profilo
Garry Michael Kann is currently the Head of Corporate Development at Endonovo Therapeutics, Inc. and a Partner at The Firebird Partnership Ltd. He obtained an undergraduate degree from Kean University.
Posizioni attive di Garry Michael Kann
| Società | Posizione | Inizio |
|---|---|---|
| ENDONOVO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/03/2022 |
The Firebird Partnership Ltd.
 The Firebird Partnership Ltd. Financial ConglomeratesFinance Provides investment services | Corporate Officer/Principal | - |
Formazione di Garry Michael Kann
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
8
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Endonovo Therapeutics, Inc.
 Endonovo Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops off the shelf regenerative products that no longer require the injection of stem cells | Health Technology |
Kean University
 Kean University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Firebird Partnership Ltd.
The Firebird Partnership Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
